Clinics And Research In Hepatology And Gastroenterology SCIE

国际简称：CLIN RES HEPATOL GAS 参考译名：肝病学和胃肠病学的诊所和研究

主要研究方向：GASTROENTEROLOGY & HEPATOLOGY 非预警期刊审稿周期：偏慢,4-8周

《肝病学和胃肠病学的诊所和研究》(Clinics And Research In Hepatology And Gastroenterology)是一本由Elsevier Masson出版的以GASTROENTEROLOGY & HEPATOLOGY为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

4区中科院分区
Q2 JCR分区
111 年发文量
2.6 IF影响因子
未开放 是否OA
51 H-index
2011 创刊年份
6 issues/year 出版周期
English 出版语言

Clinics and Research in Hepatology and Gastroenterology publishes high-quality original research papers in the field of hepatology and gastroenterology. The editors put the accent on rapid communication of new research and clinical developments and so called "hot topic" issues. Following a clear Editorial line, besides original articles and case reports, each issue features editorials, commentaries and reviews. The journal encourages research and discussion between all those involved in the specialty on an international level. All articles are peer reviewed by international experts, the articles in press are online and indexed in the international databases (Current Contents, Pubmed, Scopus, Science Direct).

Clinics and Research in Hepatology and Gastroenterology is a subscription journal (with optional open access), which allows you to publish your research without any cost to you (unless you proactively chose the open access option). Your article will be available to all researchers around the globe whose institution has a subscription to the journal.

[ 查看全部 ]

投稿咨询加急咨询

投稿热线：400-888-7501

Clinics And Research In Hepatology And Gastroenterology期刊信息

ISSN：2210-7401
出版语言：English
是否OA：未开放
E-ISSN：2210-741X
出版地区：FRANCE
是否预警：否
出版商：Elsevier Masson
出版周期：6 issues/year
创刊时间：2011
开源占比：0.105
Gold OA文章占比：27.16%
OA被引用占比：0.0018...
出版国人文章占比：0.23
出版撤稿占比：0
研究类文章占比：73.87%

Clinics And Research In Hepatology And Gastroenterology CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

4.3

0.676

0.616

学科类别	分区	排名	百分位
大类：Medicine 小类：Gastroenterology	Q2	77 / 167	54%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Clinics And Research In Hepatology And Gastroenterology中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学	4区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学	4区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学	4区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学	4区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学	4区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学	4区

Clinics And Research In Hepatology And Gastroenterology JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	67 / 143	53.5%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	70 / 143	51.4%

Clinics And Research In Hepatology And Gastroenterology历年数据统计

影响因子

中科院分区

Clinics And Research In Hepatology And Gastroenterology中国学者发文选摘

1、Comparing high-dose dual therapy with bismuth-containing quadruple therapy for the initial eradication of Helicobacter pylori infection on Hainan Island: A randomized, multicenter clinical trial
Author: Liu, Dan-Ni; Wang, Qiu-Yan; Li, Pei -Yuan; Wu, Dong-Han; Pan, Jing; Chen, Zheng-Yi; Li, Yan-Qiang; Han, Xiang-Yang; Lan, Cheng; Tang, Jing; Tan, Yan; Mo, Cui-Yi; Yang, Wei-Zhong; Han, Jun-Ling; Huang, Xiao-Xi

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 5, pp. -. DOI: 10.1016/j.clinre.2023.102125
2、Efficacy and safety of no-touch radiofrequency ablation for small hepatocellular carcinoma-a systematic review and single-arm meta-analysis
Author: Du, Fei; Zhang, Lingkai; Zhang, Yongxuan; Fan, Haining; Ren, Li

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102069
3、Metabolic-associated fatty liver disease and the risk of cardiovascular disease
Author: Zhang, Pengwei; Dong, Xianhui; Zhang, Wei; Wang, Shiyin; Chen, Chen; Tang, Jiake; You, Yao; Hu, Siqi; Zhang, Shenghui; Wang, Chunyi; Wen, Wen; Zhou, Mengyun; Tan, Tao; Qi, Guanming; Li, Li; Wang, Mingwei

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102063
4、The addition of camrelizumab is effective and safe among unresectable hepatocellular carcinoma patients who progress after drug-eluting bead transarterial chemoembolization plus apatinib therapy
Author: Wang, Manzhou; Sun, Limin; Han, Xinwei; Ren, Jianzhuang; Li, Hao; Wang, Wenhui; Xu, Wenze; Liang, Chao; Duan, Xuhua

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102060
5、Global burden of non-alcoholic fatty liver disease in 204 countries and territories from 1990 to 2019
Author: Tian, Hongzhan; Zhang, Kexin; Hui, Zongguang; Ren, Fangbing; Ma, Yanhui; Han, Fang; Sun, Xiaodong; Kan, Chengxia; Hou, Ningning

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102068
6、LncRNA ZFAS1 ameliorates injury led by non- alcoholic fatty liver disease via suppressing lipid peroxidation and inflammation
Author: Liu, Lu; Sun, Sen; Li, Xiaohua

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102067
7、Transarterial chemoembolization failure in patients with hepatocellular carcinoma: Incidence, manifestation and risk factors
Author: Zhang, Lijie; Zhang, Xin; Li, Qing; Makamure, Joyman; Liu, Ziyi; Zhao, Dan; Li, Xin; Shi, Heshui; Zheng, Chuansheng; Liu, Fengyong; Liang, Bin

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 2, pp. -. DOI: 10.1016/j.clinre.2022.102071
8、T lymphocyte-mediated pyroptosis: A new regulatory mechanism in non-viral liver disease
Author: Xiong, Wanyuan; Qian, Zibing; Mao, Xiaorong; Li, Junfeng

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 2, pp. -. DOI: 10.1016/j.clinre.2022.102070